课题基金 / 基金详情

Integration of photic and nonphotic signaling in the circadian pacemaker

Integration of photic and nonphotic signaling in the circadian pacemaker
昼夜节律起搏器中光信号和非光信号的整合
批准号:
7573591
负责人:
Karen L Gamble
金额:
$7.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-01 至 2009-09-06

项目摘要

项目成果

Karen L Gamble的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):哺乳动物生物钟驱动并维持生理学上的24小时节律,并将多个信号整合到与环境一致的相位变化中。本研究的目的是探讨哺乳动物昼夜节律起搏器视交叉上核(SCN)整合的神经肽通讯机制。长期目标是提供必要的培训,以促进受赠人从指导博士后研究职位过渡到独立的终身教职职位。在申办方的指导下,指导阶段将研究SCN内光转导期间肽(胃泌素释放肽(GRP))诱导的神经生理学变化的离子基础。这一阶段还将为教师求职和膜片钳电生理学的关键培训提供必要的时间和指导,这些培训将用于为研究计划中概述的实验建立模型范式。为了研究SCN内的昼夜节律网络如何解释冲突的相移刺激,将结合实时时钟基因成像、药理学和电生理学终点,以探索光和非光刺激的相互作用以及使用独特的动物模型(Per 1::GFP)的神经生理学和分子节律的后续变化,该动物模型允许检查个体、活的、表达Pert的细胞的神经生理学特性。具体来说,我将使用Per 7::GFP和PER 2::LUC小鼠:(1)确定并发光和非光夹带刺激的相位依赖性和转导机制,(2)研究白天与GRP介导的光转导相关的神经回路和神经生理学,(3)确定非光递质神经肽Y(NPY)的神经生理学和分子效应是否在昼夜节律周期中变化。拟议的研究计划将大大有助于建立一个成功的独立研究计划,研究昼夜神经生理学和行为的长期目标。这些研究的结果对人类健康有影响,包括与情绪障碍和轮班工作有关的昼夜节律中断。 相关性:这项研究计划将研究大脑的生物钟如何整合光和非光重置环境刺激(例如压力,运动等)同时存在。这些研究的结果将对时差反应/轮班工作、昼夜节律紊乱以及对那些患有情绪和发育障碍的人的昼夜节律中断的治疗发展产生影响。
英文摘要
DESCRIPTION (provided by applicant): The mammalian circadian clock drives and maintains 24-h rhythms in physiology and integrates multiple signals into a phase change consistent with the environment. The research goal of this proposal is to investigate neuropeptide communication underlying this integration within the primary, mammalian circadian pacemaker, the suprachiasmatic nucleus (SCN). The long-term goal is to provide essential training that will facilitate the transition of the grantee from a mentored postdoctoral research position to an independent, tenure-track faculty position. Under the direction of the sponsor, the mentored phase will investigate the ionic basis for neurophysiological changes induced by the peptide, gastrin-releasing peptide (GRP), during intra- SCN photic transduction. This phase will also provide the time and mentoring necessary for a faculty job search and critical training in patch clamp electrophysiology that will be used to establish a model paradigm for the experiments outlined in the research plan. In order to investigate how the circadian network within the SCN interprets conflicting phase shifting stimuli, real-time clock gene imaging, pharmacological and electrophysiological endpoints will be combined to explore the interaction of photic and nonphotic stimuli and the subsequent changes in neurophysiology and molecular rhythms using a unique animal model (Per1::GFP) that allows examination of neurophysiological properties of individual, living, Pert-expressing cells. Specifically, I will use Per7::GFP and PER2::LUC mice to: (1) determine the phase dependence and transduction mechanisms for concurrent photic and nonphotic entraining stimuli, (2) investigate the neural circuitry and neurophysiology associated with GRP-mediated photic transduction during the day, and (3) determine whether the neurophysiological and molecular effects of the nonphotic transmitter, neuropeptide Y (NPY), vary across the circadian cycle. The proposed research plan will substantially contribute to the long- term goal of establishing a successful independent research program studying circadian neurophysiology and behavior. The results of these studies have implications for human health, including circadian rhythm disruptions associating with mood disorders and shift work. RELEVANCE: This research plan will investigate how the brain's biological clock integrates light and nonphotic resetting environmental stimuli (e.g. stress, exercise, etc) when present simultaneously. The results of these studies will have implications for jet lag/shift work, circadian rhythm disorders, as well as treatment developments for circadian disruptions in those suffering from mood and developmental disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Circadian changes in network excitability and Alzheimer disease pathogenesis
Circadian changes in network excitability and Alzheimer disease pathogenesis
Circadian changes in network excitability and Alzheimer disease pathogenesis
Circadian dysfunction and GSK3 in neurodegenerative disease
海外基金